NCT01441661View on ClinicalTrials.gov

Sunitinib Intake Conditions in the Treatment of Patients With Renal Cell Carcinoma

CompletedOBSERVATIONAL
Enrollment

400

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

June 30, 2012

Study Completion Date

June 30, 2012

Conditions
Renal Cell Carcinoma
Trial Locations (2)

100021

Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing

430030

Tongji Hospital, Tongji Medical College of Hust, Wuhan

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

Cancer Foundation, China

OTHER